Eileen McDermott quoted from our recent report on ‘Will the USMCA’s Requirements on Regulatory Data Protection increase spending on Medicines’ in an article at IPWatchdog.
This author has yet to write their bio.Meanwhile lets just say that we are proud gnadm contributed a whooping 19 entries.
Entries by gnadm
Philip Stevens represented Geneva Network at the 2019 Summit of the GTIPA in Mexico City, joining representatives from 25 think tanks from around the world. On the agenda: Smart cities and society The impact on innovation and intellectual property on the USMCA and the EU-Mexico Modernised Trade Agreement Technology-driven transformation changing business models and global trade Challenges […]
Geneva Network and IDEAS joint roundtable on IP reform in Malaysia was profiled in Free Malaysia Today. Kyungjin Song, chairman of the International Cooperation, Innovative Economy Forum of South Korea, told the meeting that the IP industry had spurred her country’s economic growth. She said between 2010 and 2015, about 30% of Koreans worked in […]
For countries like Chile looking to reduce dependence on the export of natural resources, innovation will be key. Knowledge-based industries from life sciences to film form the basis of economic growth in most OECD countries, their growth and investment encouraged by a strong framework of intellectual property rights. Latin American countries such as Chile hold […]
Geneva Network research is quoted in this IPWatchdog article examining whether the IP provisions in the USMCA will raise medicine prices.
The U.S. Mission Geneva cosponsored today’s discussion on IP as a driver for Innovation at the WTO (World Trade Organization). A panel of four expert speakers looked at how IP incentivizes creativity in the arts, business and technology, unshackling human potential to address the world’s many challenges. The event featured four speakers: Carsten Fink, Chief […]
In the run up to the 2019 general election, the Indian government has prioritised healthcare delivery and promoting innovation and competitiveness in the country, including in the health and life sciences sector. To feed into this discussion, Geneva Network organised a half day roundtable in Mumbai to assess the state of play, and also to […]
In 2017 the Malaysian government issued a Government Use License for a Hepatitis C medicine. Following the recent change of government, Geneva Network in collaboration with local partner the Galen Centre organised a half day round table to assess the impact of this policy and to emphasise the important role of intellectual property rights in […]
As WHO member states gathered in Geneva for the 2018 World Health Assembly, Geneva Network co-ordinated a summit for pro-innovation think tanks and thought leaders from around the world. Thanks are due to the World Intellectual Property Organisation which kindly offered meeting facilities and lunch in its headquarters building. WIPO Director General Francis Gurry started the day […]
Following growing concern about the sustainability of healthcare systems, in the summer of 2016 EU Health Ministers invited the European Commission (EC) to undertake a review of the Intellectual Property (IP) incentives that underpin biomedical innovation. This document is a joint statement by a coalition of like-minded think tanks, civil society groups and academics who […]